+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Molecular Biology Enzymes, Reagents And Kits Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Enzymes), By Application (Cloning, Sequencing, PCR, Epigenetics), By End-use, By Region, And Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 150 Pages
  • June 2023
  • Region: Global
  • Grand View Research
  • ID: 5702171
Description Jump to:
The global molecular biology enzymes, reagents, and kits market size is expected to reach USD 44.67 billion by 2030, registering a CAGR of 9.65%, according to a new report by the publisher The growth of the market globally can be attributed to continuous advancement in technologies in the molecular biology field, the prevalence of infectious and chronic diseases, increased usage of sequencing technologies and growing omics-based research activities.

The COVID-19 pandemic exponentially increased the demand for molecular biology enzymes, reagents, and kits, and the continuous rise in cases worldwide kept the demand on the higher side. Many market players, healthcare organizations, and academic and research institutes were actively engaged in the development of vaccines and they increased the research for repurposing the existing therapeutics for the treatment of COVID-19 infection. This continuous R&D activity is expected to boost the demand for these products in the coming years. Moreover, in an effort to detect the SARS-CoV-2 virus faster, many new products were launched by the key market players, such as RNA extraction kits. For example, in June 2020, Omega Bio-tek, Inc. announced the launch of its “Mag-Bind Viral RNA Xpress Kit” for RNA isolation in a reliable and rapid manner from the nasopharyngeal swab of patient samples.

Continuous funding and investments in the field of synthetic biology and multi-omics are expanding the field of biotechnology. As per a press release in March 2022, The Bristol Centre for Engineering Biology, BrisEngBio, is an institute that supports research and discovery in synthetic biology. It is a UKRI-funded research center that has published over 325 research papers, collaborated with 8 biotech companies, and received an additional USD 117.90 million for research. This rapidly advancing field of synthetic biology and multi-omics will result in more extensive adoption of molecular biology, enzymes, kits, and reagent products, which serve as educational tools. And this adoption rate further enhances the development of innovative methods such as drug discovery, diagnostics development, and gene therapies manufacturing, hence driving the market significantly.

The key market players are expanding their global presence through never-ceasing product launches and sustained technological developments. Acquisitions, partnerships, collaborations, and manufacturing expansions are also some of the business strategies taken up by the key players to drive revenue generation in the market. For example, in January 2022, Illumina, Inc. announced a partnership with SomaLogic to develop a product by integrating Illumina’s NGS technology with SomaScan Proteomics Assay. This partnership bolsters the rapidly growing high-throughput segment of the proteomics market.

Molecular Biology Enzymes, Reagents, and Kits Market Report Highlights

  • By product, the kits and reagents held the largest share in 2022. The launch of new kits and reagents in response to the pandemic is one of the key reasons fueling the growth. Moreover, the repeated use of molecular biology kits and reagents in laboratory setups contributes to the growth
  • By application, sequencing accounted for the largest share in 2022 due to the introduction of single-cell sequencing and the leading presence of NGS. Use of NGS for analysis of genomics, tumor diagnostics, and biomarker discovery fuels the segment growth
  • By end-use, the pharma and biotech segment held the largest share in 2022. The presence of drug development pipelines, clinical trials, and continuous R&D activities require huge usage of molecular biology enzymes, kits, and reagents, thus leading to the segment growth
  • North America held the largest revenue share in 2022. This is attributed to the presence of numerous key pharmaceutical and biotechnology companies in the U.S. Furthermore, the prevalence of diseases in this region and increased use of molecular diagnostics contribute to revenue generation

Table of Contents

Chapter 1. Methodology And Scope
1.1. Market Segmentation And Scope
1.1.1. Segment Definitions
1.1.1.1. Product Segment
1.1.1.2. Application Segment
1.1.1.3. End-Use Segment
1.2. Information Procurement
1.2.1. Market Formulation & Data Visualization
1.2.2. Data Validation & Publishing
1.3. Research Assumptions
1.4. Research Methodology
1.4.1. Purchased Database
1.4.2. Gvrs Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details Of Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.1.1. Approach 1: Commodity Flow Approach
1.8. List Of Secondary Sources
1.9. Global Market: Cagr Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot 1
2.3. Segment Snapshot 2
2.4. Competitive Landscape Snapshot
Chapter 3. Molecular Biology Enzymes, Reagents And Kits Market Variables And Trends
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Impact Analysis
3.2.1.1. Technological Advancements In The Molecular Biology Arena
3.2.1.2. Rising Incidence Of Infectious Diseases And Genetic Disorders
3.2.1.3. Expanding Applications Of Sequencing Technology In Molecular Biology
3.2.1.4. Increase In Omics - Based R&D Programs
3.2.2. Market Restraint Impact Analysis
3.2.2.1. Challenges In Maintaining Privacy Of Genetic Information
3.2.2.2. Reimbursement Challenges For Molecular Diagnostics
3.2.3. Market Opportunities Impact Analysis
3.2.3.1. Funding And Investments In The Field Of Synthetic Biology And Epigenomics
3.2.3.2. Emergence Of Single - Cell Sequencing
3.2.4. Market Threat Impact Analysis
3.2.4.1. Challenges Pertaining To Molecular Profiling
3.2.4.2. Routine Challenges In Molecular Biology
3.3. Impact Of Covid-19 Pandemic
3.4. Industry Analysis Tools
3.4.1. Porter’s Analysis
3.4.2. Swot Analysis; By Factor (Political & Legal, Economic And Technological)
Chapter 4. Molecular Biology Enzymes, Reagents And Kits Market: Product Estimates & Trend Analysis
4.1. Product Movement Analysis & Market Share, 2022 & 2030
4.2. Molecular Biology Enzymes, Reagents And Kits Market Estimates & Forecast, By Product (USD Million)
4.3. Kits & Reagents
4.3.1. Global Kits & Reagents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4. Enzymes
4.4.1. Global Enzymes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Molecular Biology Enzymes, Reagents And Kits Market: Application Estimates & Trend Analysis
5.1. Application Movement Analysis & Market Share, 2022 & 2030
5.2. Molecular Biology Enzymes, Reagents And Kits Market Estimates & Forecast, By Application (USD Million)
5.3. Cloning
5.3.1. Global Cloning Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.4. Sequencing
5.4.1. Global Sequencing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.5. Pcr
5.5.1. Global Pcr Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.6. Epigenetics
5.6.1. Global Epigenetics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.7. Restriction Digestion
5.7.1. Global Restriction Digestion Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.8. Others
5.8.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Molecular Biology Enzymes, Reagents And Kits Market: End-Use Estimates & Trend Analysis
6.1. End-Use Movement Analysis & Market Share, 2022 & 2030
6.2. Molecular Biology Enzymes, Reagents And Kits Market Estimates & Forecast, By End-Use (USD Million)
6.3. Pharma & Biotech
6.3.1. Global Pharma & Biotech Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4. Academic & Research
6.4.1. Global Academic & Research Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5. Hospital & Diagnostics
6.5.1. Global Hospital & Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Molecular Biology Enzymes, Reagents And Kits Market: Regional Estimates And Trend Analysis
7.1. Molecular Biology Enzymes, Reagents And Kits Market: Regional Outlook
7.2. North America
7.2.1. North America Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Target Disease Prevalence
7.2.2.3. Competitive Scenario
7.2.2.4. Regulatory Framework
7.2.2.5. Reimbursement Scenario
7.2.2.6. U.S. Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. Reimbursement Scenario
7.2.3.6. Canada Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.2. Germany
7.3.2.1. Key Country Dynamics
7.3.2.2. Target Disease Prevalence
7.3.2.3. Competitive Scenario
7.3.2.4. Regulatory Framework
7.3.2.5. Reimbursement Scenario
7.3.2.6. Germany Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.3. Uk
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. Reimbursement Scenario
7.3.3.6. Uk Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Reimbursement Scenario
7.3.4.6. France Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. Reimbursement Scenario
7.3.5.6. Italy Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Reimbursement Scenario
7.3.6.6. Spain Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Reimbursement Scenario
7.3.7.6. Denmark Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Reimbursement Scenario
7.3.8.6. Sweden Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Reimbursement Scenario
7.3.9.6. Norway Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Competitive Scenario
7.4.2.4. Regulatory Framework
7.4.2.5. Reimbursement Scenario
7.4.2.6. Japan Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Reimbursement Scenario
7.4.3.6. China Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. Reimbursement Scenario
7.4.4.6. India Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. Reimbursement Scenario
7.4.5.6. South Korea Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Reimbursement Scenario
7.4.6.6. Australia Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Reimbursement Scenario
7.4.7.6. Thailand Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Competitive Scenario
7.5.2.4. Regulatory Framework
7.5.2.5. Reimbursement Scenario
7.5.2.6. Brazil Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Reimbursement Scenario
7.5.3.6. Mexico Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Reimbursement Scenario
7.5.4.6. Argentina Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. MEA Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Competitive Scenario
7.6.2.4. Regulatory Framework
7.6.2.5. Reimbursement Scenario
7.6.2.6. South Africa Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. Reimbursement Scenario
7.6.3.6. Saudi Arabia Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. Reimbursement Scenario
7.6.4.6. UAE Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. Reimbursement Scenario
7.6.5.6. Kuwait Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Molecular Biology Enzymes, Reagents And Kits Market: Competitive Landscape
8.1. Participant Categorization
8.1.1. Thermo Fisher Scientific, Inc.
8.1.1.1. Overview
8.1.1.2. Product Benchmarking
8.1.1.3. Strategic Initiatives
8.1.2. Illumina, Inc.
8.1.2.1. Overview
8.1.2.2. Product Benchmarking
8.1.2.3. Strategic Initiatives
8.1.3. Agilent Technologies, Inc.
8.1.3.1. Overview
8.1.3.2. Financial Performance (Net Revenue/Sales/Ebitda/Gross Profit)
8.1.3.3. Product Benchmarking
8.1.3.4. Strategic Initiatives
8.1.4. Qiagen
8.1.4.1. Overview
8.1.4.2. Financial Performance (Net Revenue/Sales/Ebitda/Gross Profit)
8.1.4.3. Product Benchmarking
8.1.4.4. Strategic Initiatives
8.1.5. Promega Corporation
8.1.5.1. Overview
8.1.5.2. Financial Performance (Net Revenue/Sales/Ebitda/Gross Profit)
8.1.5.3. Product Benchmarking
8.1.5.4. Strategic Initiatives
8.1.6. New England Biolabs
8.1.6.1. Overview
8.1.6.2. Financial Performance (Net Revenue/Sales/Ebitda/Gross Profit)
8.1.6.3. Product Benchmarking
8.1.6.4. Strategic Initiatives
8.1.7. Merck Kgaa
8.1.7.1. Overview
8.1.7.2. Financial Performance (Net Revenue/Sales/Ebitda/Gross Profit)
8.1.7.3. Product Benchmarking
8.1.7.4. Strategic Initiatives
8.1.8. F. Hoffmann-La Roche Ltd.
8.1.8.1. Overview
8.1.8.2. Financial Performance (Net Revenue/Sales/Ebitda/Gross Profit)
8.1.8.3. Product Benchmarking
8.1.8.4. Strategic Initiatives
8.1.9. Bio-Rad Laboratories, Inc.
8.1.9.1. Overview
8.1.9.2. Financial Performance (Net Revenue/Sales/Ebitda/Gross Profit)
8.1.9.3. Product Benchmarking
8.1.9.4. Strategic Initiatives
8.1.10. Takara Bio, Inc.
8.1.10.1. Overview
8.1.10.2. Financial Performance (Net Revenue/Sales/Ebitda/Gross Profit)
8.1.10.3. Product Benchmarking
8.1.10.4. Strategic Initiatives
8.1.11. Lgc Limited
8.1.11.1. Overview
8.1.11.2. Financial Performance (Net Revenue/Sales/Ebitda/Gross Profit)
8.1.11.3. Product Benchmarking
8.1.11.4. Strategic Initiatives
8.2. Participant’s Overview
8.3. Financial Performance
8.4. Product Benchmarking
8.5. Company Market Share Analysis, 2022
8.6. Strategy Mapping
8.6.1. Expansion
8.6.2. Acquisition
8.6.3. Product/Service Launch
8.6.4. Others
Chapter 9. Analyst View
List of Tables
Table 1: List of secondary sources
Table 2: List of Abbreviations
Table 3: Global Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 4: Global Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 5: Global Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 6: North America Molecular Biology Enzymes, Kits, & Reagents Market, by Country, 2018-2030 (USD Million)
Table 7: North America Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 8: North America Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 9: North America Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 10: Europe Molecular Biology Enzymes, Kits, & Reagents Market, by Country, 2018-2030 (USD Million)
Table 11: Europe Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 12: Europe Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 13: Europe Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 14: Asia Pacific Molecular Biology Enzymes, Kits, & Reagents Market, by Country, 2018-2030 (USD Million)
Table 15: Asia Pacific Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 16: Asia Pacific Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 17: Asia Pacific Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 18: Latin America Molecular Biology Enzymes, Kits, & Reagents Market, by Country, 2018-2030 (USD Million)
Table 19: Latin America Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 20: Latin America Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 21: Latin America Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 22: Middle East & Africa Molecular Biology Enzymes, Kits, & Reagents Market, by Country, 2018-2030 (USD Million)
Table 23: Middle East & Africa Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 24: Middle East & Africa Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 25: Middle East & Africa Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 26: U.S. Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 27: U.S. Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 28: U.S. Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 29: Canada Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 30: Canada Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 31: Canada Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 32: Germany Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 33: Germany Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 34: Germany Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 35: U.K. Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 36: U.K. Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 37: U.K. Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 38: France Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 39: France Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 40: France Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 41: Italy Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 42: Italy Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 43: Italy Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 44: Spain Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 45: Spain Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 46: Spain Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 47: Denmark Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 48: Denmark Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 49: Denmark Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 50: Sweden Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 51: Sweden Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 52: Sweden Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 53: Norway Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 54: Norway Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 55: Norway Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 56: China Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 57: China Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 58: China Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 59: Japan Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 60: Japan Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 61: Japan Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 62: India Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 63: India Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 64: India Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 65: Australia Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 66: Australia Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 67: Australia Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 68: Thailand Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 69: Thailand Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 70: Thailand Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 71: South Korea Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 72: South Korea Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 73: South Korea Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 74: Brazil Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 75: Brazil Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 76: Brazil Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 77: Mexico Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 78: Mexico Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 79: Mexico Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 80: Argentina Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 81: Argentina Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 82: Argentina Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 83: South Africa Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 84: South Africa Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 85: South Africa Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 86: Saudi Arabia Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 87: Saudi Arabia Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 88: Saudi Arabia Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 89: UAE Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 90: UAE Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 91: UAE Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 92: Kuwait Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018-2030 (USD Million)
Table 93: Kuwait Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018-2030 (USD Million)
Table 94: Kuwait Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018-2030 (USD Million)
Table 95: Company Overview
Table 96: Financial Performance
Table 97: Product Benchmarking
Table 98: Strategic Initiatives
List of Figures
Fig. 1: Molecular Biology Enzymes, Reagents And Kits market segmentation
Fig. 2: Market research process
Fig. 3: Information procurement
Fig. 4: Primary research pattern
Fig. 5: Market research approaches
Fig. 6: Value chain-based sizing & forecasting
Fig. 7: QFD modelling for market share assessment
Fig. 8: Market formulation & validation
Fig. 9: Market Outlook (2022)
Fig. 10: Segment Outlook
Fig. 11: Strategy framework
Fig. 12: Market driver relevance analysis (current & future impact)
Fig. 13: Market restraint relevance analysis (current & future impact)
Fig. 14: Porter’s five forces analysis
Fig. 15: Swot analysis, by factor (political & legal, economic and technological)
Fig. 16: Molecular biology enzymes, kits, and reagents market: Product outlook and key takeaways
Fig. 17: Molecular biology enzymes, reagents, and kits market: Product movement analysis
Fig. 18: Global molecular biology kits & reagents market, 2018-2030 (USD million)
Fig. 19: Global molecular biology enzymes market, 2018-2030 (USD million)
Fig. 20: Molecular biology enzymes, kits, and reagents market: Application outlook and key takeaways
Fig. 21: Molecular biology enzymes, reagents, and kits market: Application movement analysis
Fig. 22: Global molecular biology enzymes, reagents, and kits market for cloning, 2018-2030 (USD Million)
Fig. 23: Global molecular biology enzymes, reagents, and kits market for sequencing, 2018-2030 (USD Million)
Fig. 24: Global molecular biology enzymes, reagents, and kits market for PCR, 2018-2030 (USD Million)
Fig. 25: Global molecular biology enzymes, reagents, and kits market for sequencing, 2018-2030 (USD Million)
Fig. 26: Global molecular biology enzymes, reagents, and kits market for restriction digestion, 2018-2030 (USD Million)
Fig. 27: Global molecular biology enzymes, reagents, and kits market for other applications, 2018-2030 (USD Million)
Fig. 28: Molecular biology enzymes, reagents, and kits market: End-use outlook and key takeaways
Fig. 29: Molecular biology enzymes, reagents, and kits market: End-use movement analysis
Fig. 30: Global molecular biology enzymes, reagents, and kits market for pharma & biotech, 2018-2030 (USD Million)
Fig. 31: Global molecular biology enzymes, reagents, and kits market for academic & research, 2018-2030 (USD Million)
Fig. 32: Global molecular biology enzymes, reagents, and kits market for hospital & diagnostics, 2018-2030 (USD Million)
Fig. 33: Global molecular biology enzymes, reagents, and kits market for others, 2018-2030 (USD Million)
Fig. 34: Molecular biology enzymes, reagents, and kits market: Regional outlook and key takeaways
Fig. 35: Molecular biology enzymes, reagents, and kits market: Regional movement analysis, 2021 and 2030
Fig. 36: North America molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 37: U.S. molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 38: Canada molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 39: Europe molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 40: Germany molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 41: U.K. molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 42: France molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 43: Italy molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 44: Spain molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 45: Denmark molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 46: Sweden molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 47: Norway molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 48: Asia Pacific molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 49: Japan molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 50: China molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 51: India molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 52: Australia molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 53: Thailand molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 54: South Korea molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 55: Latin America molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 56: Brazil molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 57: Mexico molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 58: Argentina molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 59: MEA molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 60: South Africa molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 61: Saudi Arabia molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 62: UAE molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 63: Kuwait molecular biology enzymes, reagents, and kits market estimates and forecast, 2018-2030 (USD Million)
Fig. 64: List of secondary sources

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Qiagen
  • Promega Corporation
  • New England Biolabs
  • Merck Kgaa
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Takara Bio, Inc.
  • Lgc Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedJune 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 20.94 Billion
Forecasted Market Value ( USD ) by 2030 $ 44.67 Billion
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Molecular Biology Enzymes & Kits & Reagents Market by Type, Application, End-User - Global Forecast 2025-2030 - Product Image

Molecular Biology Enzymes & Kits & Reagents Market by Type, Application, End-User - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Global Molecular Biology Enzymes and Kits & Reagents Market by Product, Application and End Users, Regional Outlook - Forecast up to 2030 - Product Image

Global Molecular Biology Enzymes and Kits & Reagents Market by Product, Application and End Users, Regional Outlook - Forecast up to 2030

  • Report
  • 160 Pages
  • Global
From
Molecular Biology Enzymes & Kits & Reagents Global Market Report 2024 - Product Image

Molecular Biology Enzymes & Kits & Reagents Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Molecular Biology Enzymes and Kits & Reagents - Global Strategic Business Report - Product Image

Molecular Biology Enzymes and Kits & Reagents - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Molecular Biology Enzymes Reagents and Kits Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F - Product Image

Molecular Biology Enzymes Reagents and Kits Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.